Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Chloe Weber and Remys Revenge LLC. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Chloe Weber and Remys Revenge LLC or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Finding a CURE for rare genetic disorders

1:10:34
 
Share
 

Manage episode 495011449 series 3529081
Content provided by Chloe Weber and Remys Revenge LLC. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Chloe Weber and Remys Revenge LLC or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Get ready for one of our most meaningful conversations yet. Dr. Chloe sits down with Elizabeth DeLuca—the powerhouse advocate whose late-night PubMed searches, cross-country lab visits, and “help-the-babies” fund-raising campaigns helped push Capsida’s CAP-002 gene-therapy program all the way to FDA clearance. We unpack how this first-in-human trial aims to restore the missing STXBP1 protein, why the same technology could leapfrog into other rare epilepsies, and how a mother’s promise to her daughter is changing the face of science.

Quick links

Heads-up: We speak candidly about seizures, neuro-degeneration, and child loss. Estimated annual mortality for STXBP1 remains ~3 %—every child is one too many—and that stark reality fuels Elizabeth’s drive and Dr. Chloe’s daily fight for her son, Remy.

Listen, share, and stand with the rare-disease community that defines our world.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

  continue reading

37 episodes

Artwork
iconShare
 
Manage episode 495011449 series 3529081
Content provided by Chloe Weber and Remys Revenge LLC. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Chloe Weber and Remys Revenge LLC or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Get ready for one of our most meaningful conversations yet. Dr. Chloe sits down with Elizabeth DeLuca—the powerhouse advocate whose late-night PubMed searches, cross-country lab visits, and “help-the-babies” fund-raising campaigns helped push Capsida’s CAP-002 gene-therapy program all the way to FDA clearance. We unpack how this first-in-human trial aims to restore the missing STXBP1 protein, why the same technology could leapfrog into other rare epilepsies, and how a mother’s promise to her daughter is changing the face of science.

Quick links

Heads-up: We speak candidly about seizures, neuro-degeneration, and child loss. Estimated annual mortality for STXBP1 remains ~3 %—every child is one too many—and that stark reality fuels Elizabeth’s drive and Dr. Chloe’s daily fight for her son, Remy.

Listen, share, and stand with the rare-disease community that defines our world.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

  continue reading

37 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play